Ilenia D’Abbrunzo | Plant Microbiology | Excellence in Research Award

Dr. Ilenia D’Abbrunzo | Plant Microbiology | Excellence in Research Award

Università Degli Studi Di Trieste | Italy

Dr. Ilenia D’Abbrunzo is a chemist and pharmaceutical scientist specializing in solid-state chemistry and pharmaceutical technology. She holds a PhD in Chemistry (Doctor Europaeus) from the University of Trieste, with research focused on drug–drug solid forms, crystal engineering, and multicomponent pharmaceutical systems. Her experience includes academic teaching, supervision of master’s theses, and international research training in advanced crystallization techniques. Currently a Junior Research Fellow on a PRIN-funded project, her work centers on innovative pediatric antibiotic formulations. Her research interests span cocrystals, coamorphous systems, solid-state characterization, and formulation development, contributing to improved drug stability, bioactivity, and patient-centered pharmaceutical design.

                             Citation Metrics (Scopus)

100

80

60

40

20

0

 

Citations
55
Documents
15
h-index
5

Citations

Documents

h-index

View Scopus Profile

Featured Publications

Andra-Diana Cecan | Medicinal Plants | Research Excellence Award

Dr. Andra-Diana Cecan | Medicinal Plants | Research Excellence Award

Univeristy of Medicine and Pharmacy “Iuliu Hatieganu”, Cluj-Napoca | Romania

Dr. Andra-Diana Cecan is a physician and academic specializing in physiopathology and laboratory medicine. She earned her MD and PhD in Medicine from the University of Medicine and Pharmacy “Iuliu Hațieganu,” Cluj-Napoca, with doctoral research focused on the antitumoral potential of Mahonia aquifolium extracts. She currently serves as Șef de lucrări in Physiopathology and has extensive teaching experience across Romanian, English, and French programs. Her research interests include experimental oncology, inflammation, oxidative stress, metabolic disorders, and bioactive plant extracts. She has authored numerous ISI-indexed publications, reflecting recognized scientific contribution. Her work integrates education, research excellence, and translational biomedical impact.

                     Citation Metrics (Scopus)

200

150

100

50

10

0

 

Citations
101
Documents
8
h-index
6

Citations

Documents

h-index

View Scopus Profile

Featured Publications

Elisa Buzzatti | Medicine | Research Excellence Award

Dr. Elisa Buzzatti | Medicine | Research Excellence Award

University Tor Vergata | Italy

Elisa Buzzatti is a physician–scientist and hematologist with advanced training in medical biotechnology and translational medicine. She earned her medical degree and specialization in Hematology at the University of Rome “Tor Vergata” and is currently enrolled in a doctoral program in Medical Biotechnology and Translational Medicine. Her clinical and research experience spans stem cell transplantation, acute and chronic leukemias, myeloproliferative disorders, and phase II–III clinical trials. She has contributed to numerous high-impact, peer-reviewed international publications and multicenter studies. Her research focuses on leukemia biology, immunotherapy, infectious complications, and measurable residual disease, aiming to improve precision and outcomes in hematologic malignancies.

                    Citation Metrics (Scopus)

400

300

200

100

10

0

 

Citations
241
Documents
35
h-index
10

Citations

Documents

h-index

View Scopus Profile   View Google Scholar Profile

Featured Publications

Shiva Vaheb Hosseinabadi | Genetics and Bioinformatics | Young Scientist Award

Ms. Shiva Vaheb Hosseinabadi | Genetics and Bioinformatics | Young Scientist Award

Zist Fanavari Novin biotechnology Institute | Iran

Dr. Shiva Vaheb Hosseinabadi is a molecular and cellular biologist and researcher currently serving as a molecular-techniques instructor and research supervisor at Zist Fanavari Novin Biotechnology Institute (since 2024). She earned her M.Sc. in Cellular and Molecular Sciences from Razi University (2019) and a B.Sc. in Molecular and Cellular Biology-Genetics from Islamic Azad University of Falavarjan. Her research and technical expertise span gene expression analysis, neurogenetics, cancer genomics, mutation analysis, next-generation sequencing (NGS), and bioinformatics. She has contributed to over a dozen peer-reviewed research articles — including studies on microRNA regulation in Parkinson’s disease models, co-frameshift mutations in acute myeloid leukemia, neurotoxicity attenuation via miR-361-5p, and exploration of lncRNA–miRNA networks in various cancers — with total publications exceeding 15 and cumulative citations in the low hundreds [exact citation count varies by database]. Dr. Hosseinabadi is proficient in molecular lab techniques (PCR/qPCR, cell culture, NGS), data analysis (R, Python, SPSS), and bioinformatics workflows. Her dual role as scientist and educator allows her to translate cutting-edge genetic research into practical training and application, contributing to advances in personalized medicine, neurogenetics, cancer biomarker discovery, and genomic diagnostics. Her ongoing work, including a 2025 book on cancer diagnostics and drug-resistance, underscores her commitment to bridging research and clinical translation.

Profile: Google Scholar

Featured Publications

Hosseinabadi, S. V., Tahamtan, H., Esfahani, M. M., Ghaedi-Heidari, R., Hashemi, M. S., Peymani, M., Sisakhtnezhad, S., Fahimi, H., & Ghaedi, K. (2025). Upregulation of miR-361-5p attenuates MPP+-induced neurotoxicity in dopaminergic SH-SY5Y cells as a Parkinson’s disease model. Journal of Biological Chemistry.

Roshani, H. R., Nasiri, A., Sattari, A., Rasaei, S., Karimian, P., Jannesari, F., … Hosseinabadi, S. V., & Azadeh, M. (2025). Uncovering an ADH1C–lncRNA regulatory axis linking alcohol metabolism to diagnostic potential in colorectal, breast, and gastric cancers.

Ghasroldasht, M. M., Hosseinabadi, S. V., Ebrahimi Askari, R., & Lotfalipour, R. (2025). Novel co-frameshift mutations in N- and C-terminal regions of CEBPA in acute myeloid leukemia: A case report. Cancer Genetics.

Esfahani, M. M., Mostashfi, M., Hosseinabadi, S. V., Hashemi, M. S., Peymani, M., & Nasr-Esfahani, M. H., et al. (2024). Unveiling the regulatory role of miR-101-3p on ZNF746 in a Parkinson’s disease cell model: Implications for therapeutic targeting. Neuroscience Research.

Mansoureh Azadeh | Genetics and Bioinformatics | Excellence in Research award

Prof. Dr. Mansoureh Azadeh | Genetics and Bioinformatics | Excellence in Research award

Zist Fanavari Novin Biotechnology Institute | Iran

Dr. Mansoureh Azadeh Jouneghani is a seasoned molecular and cellular biologist, currently CEO of PreventiGene — a startup she launched in 2023 to promote cancer prevention through advanced genetic testing. With a Ph.D. in Cellular and Molecular Biology, she also founded and leads Zist Fanavari Novin Biotechnology Institute since 2011, and has taught at the university level for 20 semesters at Azad University. Over her career she has led and managed substantial research initiatives in cancer genomics, drug-resistance mechanisms in cancer (especially breast cancer), genomic biomarkers for multiple sclerosis and cardiovascular disease, athlete genomics for performance and injury prevention, and personalized medicine. She is proficient in gene expression analysis, RNA sequencing, CRISPR, bioinformatics, and high-throughput data analytics, and has supervised training in numerous molecular-biology lab techniques (PCR, qRT-PCR, ELISA, cell culture, Western blot). Her research output includes over 100 publications, covering peer-reviewed articles, conference papers, and laboratory-technique handbooks; her work has contributed significantly to genomic medicine and translational biotechnology. As a leader and educator she bridges academia, industry, and clinical research — advancing personalized medicine, improving genomic diagnostics, and fostering vocational biotech education. Her dedication continues to contribute to better health outcomes, scientific innovation, and capacity-building in biotechnology.

Profile: Google Scholar

Featured Publications

Azadeh, M., Salehzadeh, A., Ghaedi, K., & Talesh Sasani, S. (2022). NEAT1 can be a diagnostic biomarker in breast cancer and gastric cancer patients by targeting XIST, hsa-miR-612, and MTRNR2L8: Integrated RNA targetome… Genes and Environment.

Fattahi Dolatabadi, N., Dehghani, A., Shahand, E., Yazdanshenas, M., et al. (2020). The interaction between MALAT1 target, miR-143-3p, and RALGAPA2 is affected by functional SNP rs3827693 in breast cancer.

Adami, B., Tabatabaeian, H., Ghaedi, K., Talebi, A., Azadeh, M., & Dehdashtian, E. (2019). miR-146a is deregulated in gastric cancer. Journal of Cancer Research and Therapeutics.

Assad Samani, L., Javadirad, S. M., Parsafar, S., Tabatabaeian, H., Ghaedi, K., et al. (2019). TP53 rs1625895 is related to breast cancer incidence and early death in Iranian population. Indian Journal of Clinical Biochemistry.

Dehghan, Z., Sadeghi, S., Tabatabaeian, H., Ghaedi, K., Azadeh, M., Fazilati, M., et al. (2017). *ESR1 single nucleotide polymorphism rs1062577 (c.3804T>A) alters the susceptibility of breast cancer risk in Iranian population. Gene.

Dekui Zhang | Host-Pathogen Interactions | Best Researcher Award

Prof. Dr. Dekui Zhang | Host-Pathogen Interactions | Best Researcher Award

The Second Hospital of Lanzhou University | China

Prof. Dr. De-Kui Zhang is a distinguished gastroenterologist and Principal Investigator recognized for his extensive research in Helicobacter pylori infection, inflammatory bowel disease (IBD), gastrointestinal motility disorders, and behavioral gastroenterology. He received advanced academic training in clinical gastroenterology and molecular pathogenesis, progressing to a leading research and academic role in China. With over h-index of 19, 1345 citations, and 116 total documents, he has significantly shaped current understanding of host–pathogen interactions and chronic microbial infection. He has including four NSFC grants, advancing molecular models of microbial pathogenesis and contributing to clinical diagnostic innovations. His scholarly contributions include co-editing the academic volume Health Management of Gastritis, while his leadership roles in national academic committees—particularly within the Helicobacter pylori Group of the Chinese Society of Gastroenterology—underscore his influence on clinical guidelines and national research priorities. His work has been recognized with prestigious distinctions such as the Gansu Provincial Scientific Progress Second Prize, highlighting his impact on improving digestive health outcomes. Prof. Zhang continues to mentor emerging medical scientists and strengthen national collaborations, contributing broadly to translational gastroenterology research and patient care advancement.

Profiles: Scopus | Orcid

Featured Publications

Ma, X., Li, M., Wang, X., Xu, H., Jiang, L., Wu, F., Wei, L., Qi, G., & Zhang, D. (2024). Dihydromyricetin ameliorates experimental ulcerative colitis by inhibiting neutrophil extracellular traps formation via the HIF-1α/VEGFA signaling pathway. International Immunopharmacology.

Liu, N., Luo, Q., Gou, L., Shen, X., & Zhang, D. (2024). Knowledge and practices of Helicobacter pylori infection management among physicians in Gansu Province, China: A cross-sectional study. Helicobacter.

Gou, L., Yang, X., Yun, J., Ma, Z., Zheng, X., Du, H., & Zhang, D. (2024). Roles of the components of the cag-pathogenicity island encoded type IV secretion system in Helicobacter pylori. Future Microbiology. Advance online publication.

Ma, X., Li, J., Li, M., Qi, G., Wei, L., & Zhang, D. (2024). NETs in fibrosis: Bridging innate immunity and tissue remodeling. International Immunopharmacology.

Xu, H., Huang, K., Shi, M., Gong, H., Han, M., Tian, W., Wang, X., & Zhang, D. (2024). MicroRNAs in Helicobacter pylori-infected gastric cancer: Function and clinical application. Pharmacological Research,

Junkang Zhao | Nutritional epidemiology | Best Researcher Award

Assoc. Prof. Dr. Junkang Zhao | Nutritional epidemiology | Best Researcher Award

Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Taiyuan | China

Dr. Junkang Zhao is a nutritional epidemiologist and health statistician affiliated with Shanxi Bethune Hospital, Third Hospital of Shanxi Medical University. He earned his Ph.D. in Epidemiology and Health Statistics from Shanxi Medical University in 2022. Dr. Zhao’s research primarily focuses on the application of advanced statistical methods in nutritional and medical research, with particular emphasis on dietary pattern analysis, chronic disease epidemiology, and population health. Over the course of his career, including the highly cited review “A Review of Statistical Methods for Dietary Pattern Analysis” (Nutrition Journal, 2021), and has contributed to three National Natural Science Foundation projects while leading two provincial-level research initiatives. His work has garnered significant recognition, including a third prize in a national-level competition. Dr. Zhao actively serves on multiple professional committees, including the Medical and Biostatistics Committee of the China Field Statistics Research Association, Clinical Research and Transformation Committee of the Shanxi Physicians Association, and the Clinical Trials Professional Committee of the Shanxi Anti-Cancer Association. With an H-index reflecting his impactful contributions, and numerous citations and publications to his credit, Dr. Zhao continues to advance evidence-based approaches in nutrition and health research, fostering the translation of statistical insights into clinical and public health applications.

Profile: Orcid

Featured Publications

Wang, J., Chen, S., Zhao, J., Liang, J., Gao, X., Gao, Q., He, S., & Wang, T. (2022). Association between nutrient patterns and hyperuricemia: Mediation analysis involving obesity indicators in the NHANES. BMC Public Health.

Wang, J., Chen, S., Zhao, J., Liang, J., Gao, X., Gao, Q., He, S., & Wang, T. (2022). Association between nutrient patterns and hyperuricemia: Mediation analysis involving obesity indicators for NHANES study .

Zhao, J., Guo, W., Wang, J., & Wang, T. (2022). Exploring the association of dietary patterns with the risk of hypertension using principal balances analysis and principal component analysis. Public Health Nutrition.

Zhao, J., Li, Z., Gao, Q., Zhao, H., Chen, S., Huang, L., Wang, W., & Wang, T. (2021). A review of statistical methods for dietary pattern analysis. Nutrition Journal.

Liang, J., Zhao, J. K., Wang, J. P., & Wang, T. (2020). Association between animal source foods consumption and risk of hypertension: A cohort study. European Journal of Nutrition.